American College of Cardiology (ACC) - Company Research Report
Company Overview
Name and Mission
- Name: American College of Cardiology (ACC)
- Mission: To transform cardiovascular care and improve heart health for all.
Foundation Details
- Founded: 1949
- Founding Members: 13 cardiologists led by Franz Groedel, MD, MACC and Bruno Kisch, MD, MACC.
Key People
- 2023-2024 President: B. Hadley Wilson, MD, MACC
- CEO: Cathy Gates
Headquarters
- Location: Heart House, 2400 N St. NW, Washington, DC 20037, USA
Number of Employees
- Approximate Staff Members: Over 500
Revenue
- Financial Overview: Detailed revenue and expenses reports are available annually. Recent financials are outlined in the 2023 annual report.
Known For
- Key Areas: ACC is known for being a premier professional home for cardiovascular clinicians and researchers, providing cutting-edge education, science, and research. The college is integral in developing guidelines for cardiovascular care and forming strategic advocacies and communities.
Products
Product Offerings
1. CMP (Certification Maintenance Programs)
- Description: Aids continuous learning and provides a pathway for maintaining ABIM certification.
- Features: Free self-assessment programs tailored for ongoing education.
2. ACC Anywhere
- Description: A comprehensive video library of ACC’s educational content.
- Features: Easy access to live and virtual educational resources.
3. ACCSAP (ACC Self-Assessment Program)
- Description: Offers self-assessment opportunities in the field of adult clinical cardiology.
- Features: Over 600 case-based practice questions for learners.
4. CATHSAP
- Description: Resources for interventional cardiology.
- Features: Practice questions and quizzes to stay certified and up-to-date.
5. ECHOSAP
- Description: Prepares users for echo EMC.
- Features: Board-style questions and echo images to meet IAC requirements.
Recent Developments
Recent Science and Innovations
- Innovations in Cardiovascular Care: Recent studies presented at AHA 2024 emphasize AI and Smart Cardiology innovations to enhance heart health.
Trials and Research
- OPTION Trial: Explored the efficacy of left atrial appendage closure compared to oral anticoagulation in patients with atrial fibrillation undergoing ablation.
- BRAIN-AF Trial: Evaluated the impact of rivaroxaban on cognitive decline and stroke prevention.
- VANISH2 Trial: Compared the effectiveness of catheter ablation versus antiarrhythmic drugs in patients with ischemic cardiomyopathy.
Strategic Initiatives
- Health Equity and Inclusivity: ACC is advancing initiatives to address health disparities and advocate for inclusivity within the cardiovascular community.
- 75th Anniversary Gala: Celebrating ACC’s legacy and contributions over 75 years with a gala event planned for March 28, 2025.
Partnerships and Collaborations
- Global Collaborations: ACC continues collaborations to address global cardiovascular challenges and promote heart health solutions worldwide.
This concludes the detailed report on the American College of Cardiology (ACC). For more in-depth information on specific initiatives or to access the latest reports and financials, please refer to relevant sections of their annual publications or ACC.org.